1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Chelating Agents: new trials by email Literature Review of Chelating Agents trials Research Report on Chelating Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients ICL670, Chelation, No chelation - Aplastic Anemia | Phase 4 | Terminated | Novartis Pharmaceuticals | 15 | 2014-06-23 | 2019-08-16 |
| Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients Deferasirox - Myelodysplastic Syndromes, Iron Overload | Phase 4 | Completed | Novartis Pharmaceuticals | 24 | 2005-09-01 | 2021-06-24 |
Anemia, Aplastic (1) · Iron Overload (1) · Myelodysplastic Syndromes (1)
Russia (1) · United States (1)